SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-10
👔
Metagenomi Therapeutics, Inc.
@MGX_InsiderForm 4 Filing: Wapnick Pamela Sells $2K of $MGX
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
Metagenomi Therapeutics, Inc.
Ticker: $MGX
Transaction Value
$2K
Price/Share: $1.16
transaction date
2026-09-08
Shares: 1,911
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wapnick Pamela, holds the title of Chief Financial Officer at Metagenomi Therapeutics, Inc..
On 2026-09-08, the insider transacted 1,911 shares.The shares were transacted at a weighted average price of $1.16 per share, resulting in a total market-relevant value of $2K.
Executive Summary Summary
Wapnick Pamela (Chief Financial Officer) sold $2K of $MGX
Post-Transaction Position: 206,580 shares
SEC Accession No: 0001193125-26-387786 (CIK: 1995657)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.